Ann: Significant New Findings Published on Midkine, page-9

I don't have to take it to the board. I am sure they read these posts and if they have any conscious, they will consider it. Why don't they seriously spend time looking for partners now that they have more information on Midkine? They have enough skills in-house to put together a case for partnership with rich biotech companies if indeed the drug has so much potential. This should be one of 'Cellmid's (CEO) immediate key task.